ORTEXORTEX News
Tracking EVCM? Get live short interest, options flow, and signals on ORTEX.Sign up free →
EV
Earnings PreviewEVCM

EverCommerce Heads Into Q3 With Borrowing Market Near Frozen

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 3 Nov 2026, 05:08

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

EVCM arrives at its November 5 earnings print with the borrow market almost entirely locked up, a dynamic that makes the stock unusually sensitive to whatever the numbers deliver.

The lending side of the story is the clearest setup. Availability has collapsed to just 0.55%, meaning there is effectively one share available to borrow for every 180 already lent out. That is roughly where availability has been for most of the past six weeks, with only a brief window in mid-to-late October when it loosened to around 5% to 12% before snapping shut again. Cost to borrow has eased from its October peak above 300%, but at nearly 74% it remains punishing for anyone carrying a short position. The ORTEX short score has climbed to 97 out of 100, the highest decile of the entire universe, driven not by a particularly large short position (SI sits at just over 1% of free float) but by the near-total exhaustion of the lending pool. Anyone who wants to add short exposure into the print faces a very high cost to do so.

The stock itself has done shorts a favour going in: EVCM fell nearly 6% on the day before this writing and is down 11% on the week, trading at $8.62. That is a sharp move even allowing for sector softness. Peers CGNT and OTEX both fell less than 3% on the same day, and VERX actually rose. The underperformance looks idiosyncratic rather than macro. The recent prior-quarter print is not encouraging context: the stock dropped roughly 11% the day after its August results and slid a further 5 points over the following week.

Analyst sentiment has been drifting negative for some time. The most recent notes, from August, show RBC Capital trimming its target to $10 while keeping a neutral stance, and Barclays nudging its target up slightly to $10 while maintaining Underweight. Goldman Sachs holds a Sell with an $8 target, updated in March. The lone constructive voice in recent coverage is Canaccord, which carries a Buy and a $13 target from May. With the stock at $8.62, the mean target of $11 implies meaningful upside on paper, but the direction of travel for most covering analysts has been to trim rather than lift. The bull case centres on payments volume growth and a broadening installed base, particularly the climb in multi-solution customers. Bears point to revenue concentration in SMB clients and the structural limits of selling deeply into a niche vertical.

On ownership, two private equity backers, PSG Equity and Silver Lake, between them account for roughly 86% of shares. That concentration means the true tradeable float is thin, which amplifies both the borrow tightness and price moves in either direction. Eric Remer, a director who holds a 7.5% stake disclosed in a Schedule 13G/A in August (stakes are as-last-disclosed around the 5% threshold and can fall below that without a further filing), sold a small number of shares in mid-September. The president, Matthew Feierstein, sold 10,000 shares on October 1 under a pre-arranged 10b5-1 plan, a mechanical sale rather than a discretionary signal.

The November 5 print will test whether EVCM can demonstrate enough operational progress to offset the scepticism baked into a near-90% cost to borrow and a stock that has already shed more than a tenth of its value in a single week.

Stocks in this article

See the live data behind this article on ORTEX.

Open EVCM on ORTEX →

How this article was generated

Generated
3 Nov 2026, 06:02
Data as of
3 Nov 2026, 05:08
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
Validation notes
  • soft: missing section mentions: short interest (informational only)

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.